HSP90B2P and neoplasm: These results raise the possibility that acoustic immune priming by LOFU could increase the immunogenic potential of RT by providing HSP-chaperoned peptide antigens and danger signals released from dying irradiated tumor cells, to activate both the innate and adaptive immune response against tumors.